Skip to Main Content

The Psychedelic Reawakening

How Psilocybin, MDMA, Ketamine, LSD, and DMT Are Changing Lives

Foreword by Rick Doblin
Published by Park Street Press
Distributed by Simon & Schuster

LIST PRICE ₹969.00

PRICE MAY VARY BY RETAILER

About The Book

• Examines the contemporary psychedelic phenomenon, including the history of criminalization and legalization, psychedelics’ effects on the brain, recent clinical research, and new therapeutic potentials

• Explores substances like psilocybin, LSD, DMT, ayahuasca, ketamine, and MDMA, including scientific evidence for psychedelics’ potential to treat addiction, depression, anxiety, trauma, and neurodegenerative diseases

• Includes extensive practical information on safety, risk, and harm reduction for both laypeople and mental health practitioners

Presenting a comprehensive guide to the exciting new landscape around psychedelics, psychopharmacologist and researcher Anton Gomez-Escolar examines the long history of criminalizing and (slowly) legalizing these substances and their increasingly demonstrable positive effects on body, mind, and spirit.

Exploring substances like psilocybin, LSD, DMT, ayahuasca, ketamine, MDMA, and others, Gomez-Escolar looks at the multitude of scientific studies providing critical evidence for psychedelics’ ability to treat addiction, depression, anxiety, and trauma, as well as their potential to treat neurodegenerative diseases such as Alzheimer’s. He provides key information for therapists and other health practitioners as well as exploring the benefits of microdosing and the specific ways in which mental health issues related to COVID-19 could be alleviated by psychedelics. Breaking down substances by type, the author looks at the main risks of each psychedelic and its benefits, best harm-reduction strategies, and the neural pathways they affect. Gomez-Escolar also includes a large selection of resources for people seeking to engage personally with psychedelics for healing.

About The Author

Anton Gomez-Escolar, MPH, MIR, MSc, is a psychopharmacologist who has been working on harm reduction, psychedelic research, and drug science communication for more than a decade at organizations like the European Drugs Agency (EUDA). He is a member of the UNAD Global Drug Policy Commission, and cofounder and board member of the Spanish Society of Psychedelic Medicine (SEMPsi), the INAWE Foundation for the advancement of psychedelic science, and the Psychedelic Society of Madrid. He lives in Madrid.

Product Details

  • Publisher: Park Street Press (March 11, 2025)
  • Length: 320 pages
  • ISBN13: 9798888500033

Resources and Downloads

High Resolution Images